The MATAspire intervention is a web-app designed to promote substance misuse prevention education and bolster protective coping skills whereby students complete six weekly interactive modules using a smart device or computer. Each module is approximately 15-20 minutes long and focuses on select substances and coping strategies: (i) adaptive coping strategies, (ii) alcohol, (iii) cannabis, (iv) nicotine, (v) prescription drugs and opioids, (vi) final module. The modules are based on key theoretical constructs, behavior change strategies, and practical module components: attitudes (knowledge), perceived susceptibility (risk perceptions), and subjective norms (normative re-education). The intervention will be evaluated via a time series design using a sample of (\~1000 students) randomly assigned to either the intervention or the control conditions at a public institution in Southern California.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
1,000
Substance misuse prevention education and adaptive coping skills
Change from baseline alcohol use behavior at 3 months
Measured as the number of days drinking alcohol in past 30-days
Time frame: Baseline and 90-days following intervention completion
Change from baseline binge drinking at 3 months
Measured as the number of days consumed five or more alcoholic beverages at the same time for males; four or more for females in past 30-days
Time frame: Baseline and 90-days following intervention completion
Change from baseline cannabis use at 3 months
Measured as the number of days smoking, vaping, dabbing, oral (edibles/gummies/drinks), sprays, tinctures, and topically in past 30-days
Time frame: Baseline and 90-days following intervention completion
Change from baseline nicotine use at 3 months
Measured as the number of days using menthol cigarettes, regular cigarettes, loose tobacco rolled into cigarettes or cigars, pipe tobacco, snuff, chewing tobacco, dipping tobacco, snus, and others in past 30-days
Time frame: Baseline and 90-days following intervention completion
Change from baseline electronic vape use products at 3 months
Measured as the number of days using vaporizers, vape pens, hookah pens, electronic cigarettes, e-pens, or electronic nicotine delivery systems in past 30-days
Time frame: Baseline and 90-days following intervention
Change from baseline non-prescribed prescription drug use behavior at 3 months
Measured as the number of days used stimulants, sedatives, benzodiazepines, and prescription opioids in past 30-days
Time frame: Baseline and 90-days following intervention completion
Change from baseline coping skills at 3 months
Measured as the degree of effective and ineffective ways to cope with a stressful life event in ...
Time frame: Baseline and 90-days following intervention completion
Change from baseline alcohol use related outcomes at 3 months
Measured as participants who report any past 30-day alcohol use indicate how many times they have experienced select outcomes in the last 30 days while drinking alcohol, or as a result of their alcohol use
Time frame: Baseline and 90-days following intervention completion
Change from baseline nicotine use related outcomes at 3 months
Measured as participants who report any past 30-day nicotine use indicate how many times they have experienced ten select outcomes in the last 30 days while using nicotine, or as a result of their nicotine use.
Time frame: Baseline and 90-days following intervention completion
Change from baseline cannabis use related outcomes at 3 months
Measured as participants who report any past 30-day cannabis use indicate how many times they have experienced ten select outcomes in the last 30 days while using cannabis, or as a result of their cannabis use
Time frame: Baseline and 90-days following intervention completion
Change from baseline non-prescribed prescription drug use related outcomes at 3 months
Measured as participants who report any past 30-day non-prescribed prescription drug use indicate how many times they have experienced ten select outcomes in the last 30 days while using prescription drugs not prescribed to them, or for the purpose of feeling or experiencing something
Time frame: Baseline and 90-days following completion of intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.